Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

To celebrate its 10th anniversary, the prestigious journal Cells launched a series of Special Issues in 2021. The Special Issue entitled “10th Anniversary of Cells—Advances in Cell Cycle” was launched together with other sister Special Issues under the umbrella “10th Anniversary of Cells.” The cell cycle is a series of events that drives cells to divide and produce two new daughter cells. The typical cell cycle in eukaryotes is composed of the following phases: G1, S, G2, and M phases. Cell cycle progression is mediated by cyclin-dependent kinases (CDKs) and their regulatory cyclin subunits. CDKs, such as CDK4/6, CDK2, and CDK1 (also known as CDC2), are serine/threonine kinases with a wide variety of substrates. CDKs are activated mainly by binding to their cyclin partners, whose expressions rise and fall throughout the cell cycle to mediate the temporal activation of each CDKs. Various cell cycle checkpoints exist to ensure that critical processes are engaged prior to progression to the next phase. These cell cycle checkpoints are the G1 (restriction) checkpoint, the G2/M DNA damage checkpoint, and the spindle assembly checkpoint (SAC).This Special Issue attracted the attention of many scientists in the cell cycle field and consists of 10 high quality papers, including four research articles and six scientific reviews: a great success. The four research articles focus on various important topics of the cell cycle using a broad range of model organisms, including yeast, sea urchins, green algae, and human cancer cell lines.

Research & information: general --- Biology, life sciences --- microalgae --- Desmodesmus quadricauda --- cell cycle --- starch --- lipids --- polyphosphate --- guanine --- confocal Raman microscopy --- prenatal life --- perinatal life --- 5-bromo-2′-deoxyuridine --- cerebellar neuroepithelium --- external granular layer --- neurogenetic timetables --- neurogenetic gradients --- apoptosis --- M2 muscarinic receptor --- glioblastoma --- aberrant mitosis --- mitotic spindle --- Leishmania spp. --- leishmaniases --- telomeres --- telomerase --- growth factors --- receptor tyrosine kinases --- G1 phase --- S phase --- G2 phase --- M phase --- Ras/Erk --- PI3K/Akt --- vitelline layer --- fertilization --- sea urchin eggs --- plasticity --- Ca2+ signaling --- actin --- DTT --- TCEP --- BPA-C8-Cy3 --- electron microscopy --- Nud1 --- Cdc15 --- MEN --- mitotic exit --- Dbf2 --- Mob1 --- spindle position checkpoint --- HSF1 --- HSF2 --- cell cycle arrest --- APC/C complex --- CDK --- CTD phosphatase --- RNA polymerase II --- CTD code --- transcription --- LDIR --- hormesis --- cancer --- p21Waf1(CDKN1A) --- n/a --- 5-bromo-2'-deoxyuridine

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The word "cancer" is associated with at least 100 different pathologies, depending on the organ involved and the type of tumor developed. Cancer is a complex disease involving multiple pathogenetic mechanisms. Characterization of different types of cancers, which distinguishes them from healthy cells and other cancers, allows for the identification of specific targets for each individual tumor. The principle of chemotherapy is based on interference with the mechanisms that regulate the life and proliferation of cancer cells, causing their death. In recent years, there has been continuous progress in the development of therapeutic agents against cancer, which is ongoing.The Anticancer Inhibitors Special Issue focuses on new target-based anticancer agents that inhibit a specific target involved in the suppression of various types of cancer and the control of their chemoresistance.There is a collection of research and review articles on advances in drug discovery, design, and development of new inhibitor compounds with potency against various cancer types.

breast cancer --- tamoxifen --- LY294002 --- synergism --- apoptosis --- cell cycle --- tea (Camellia sinensis) flowers --- BTFS --- A2780/CP70 ovarian cancer cells --- S phase cell cycle arrest --- nicotinamide phosphoribosyltransferase --- NAD+ biosynthesis --- inhibitor --- azacyclohexane --- anticancer drug --- drug design --- enthalpy effect --- NSCLC --- Cathepsin K --- cell proliferation --- cell migration --- cell invasion --- mTOR --- isatin-hydrazones --- cytotoxicity --- CDK2 inhibitor --- ATP competitive inhibitor --- ADME analysis --- receptor tyrosine kinases --- protein-protein interactions --- protein engineering --- directed evolution --- angiogenesis --- binding affinity --- agonistic activity --- saponins --- phytochemicals --- tea (Camellia sinensis) flower --- ovarian cancer --- autophagy --- ZMYND8 --- tumorigenesis --- epigenetic regulation --- pro-oncogenic effects --- tumor suppression --- tacrine-coumarin derivatives --- DNA --- topoisomerases I, II --- lung carcinoma cells --- A549 --- chemotherapy --- prodrug --- drug targeting --- overexpressed enzymes --- ADC --- ADEPT --- GDEPT --- LEAPT --- PROTAC --- cyclin-dependent kinase --- cancer --- resistance --- small molecule inhibitors --- PROTACs --- statins --- pancreatic cancer --- DNA microarray --- pitavastatin --- cerivastatin --- simvastatin --- fluvastatin --- atorvastatin --- pravastatin --- HMG-CoA reductase inhibitors --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book explores the biology of the fungal pathogen Candida albicans, its interaction with the human host, and current research that seeks to identify new ways to combat the health risks posed by C. albicans infection.

Candida albicans --- acridine --- antifungal --- topoisomerase --- inhibitor --- candidiasis --- 1,3,4-oxadiazole --- drug discovery --- antifungal agents --- drug resistance --- toxicity --- biofilm --- invasive Candida infections --- invasive fungal infections --- antifungal prophylaxis --- newborns --- surgery --- neonatal surgery --- multivalency --- anti-adhesion glycoconjugates --- glycomimetics --- Candida --- C. albicans --- XCL1 --- metamorphic protein --- fold-switching protein --- antifungal peptide --- polymorphism --- hyphal morphogenesis --- hyphal activation --- signal transduction pathways --- cell cycle regulation --- sphingolipids --- myriocin --- fungal infections --- epigenetic --- yeast --- chromatin --- hyphae --- human fungal pathogen --- nutrient sensing --- amino acid metabolism --- proline catabolism --- mitochondria --- SPS-sensor --- nitrogen catabolite repression --- glucose repression --- immunometabolism --- metabolism --- macrophages --- epithelial cells --- glycolysis --- glucose --- moonlighting proteins --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Cereal foods comprise a large variety of products that make up the main part of the diet of the world population. Despite decades of research to improve cereals and cereal food quality, worldwide research coordination is now required due to market needs, processing, and climate change. Cereals and cereal foods are an important source of energy (carbohydrates, proteins, and fat), and offer a range of non-nutrient bioactive components (i.e., vitamins, minerals, dietary fiber, and phytochemicals) that provide different grades of health benefits. The main challenges for the near future include the exploration, valorization, and improvement of genetic variation for nutrients and bioactive food components; the use and implementation of biotechnological, preprocessing, and processing strategies to improve content; and the evaluation of health properties for health claims.

Research & information: general --- Biology, life sciences --- coix seed --- Monascus purpureus --- antioxidant --- fermentation --- HEp2 --- buckwheat --- dehulling --- germination --- LC-MS --- free phenolic --- bound phenolic --- antioxidant activity --- sorghum --- phenolic compounds --- cell growth inhibition --- cell cycle analysis --- apoptosis --- HepG2 --- Caco-2 --- wheat --- nutrients --- celiac disease --- wheat allergy --- non-celiac wheat/gluten sensitivity --- durum wheat --- milling fractions --- air-classification plant --- micronization plant --- sorghum phenolics --- anti-inflammatory --- anti-proliferative --- anti-diabetic --- anti-atherogenic --- Triticum aestivum L. --- Triticum durum Desf. --- gluten --- breadmaking --- durum grains --- genetic variability --- heritability --- climate constraints --- yield performance --- air-classified fractions --- alveographic properties --- antioxidants --- starch --- ATI --- glutenins --- gluten strength --- grain protein content --- haplotypes --- SNPs --- milling methods --- dietary fiber --- phenolic acid --- steamed bread --- leavened pancake --- multiple linear regression (MLR) --- artificial neural network (ANN) --- milled rice --- enzymes --- air classification --- inorganic contaminants --- organic contaminants --- arsenic --- mycotoxins --- maize inbred lines --- nutritional value --- protein quality --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The importance of natural products, and especially plant secondary metabolites, for the treatment of diseases and drug development has already been obvious in medicine for several thousand years. Thus, this Special Issue of MDPI Biomedicines collects eight top articles from the field as regular full papers in addition to five reviews. All of the published papers are a vibrant source of information on the therapeutic potential of plant secondary metabolites in the treatment of diseases and drug development.

Cannabis sativa (Cannabis) --- cannabinoids --- tetrahydrocannabinol (THC) --- cannabidiol (CBD) --- cannabinoid receptors (CB1 and CB2) --- Papaver somniferum (opium poppy) --- secondary metabolites --- ursolic acid --- NSCLC --- tumorsphere --- EGFR --- STAT3 --- MMP2 --- PD-L1 --- MAFLD --- tanshinone IIA --- phytochemical --- lipogenesis --- lipid accumulation --- LXRα --- malaria --- quinine --- chloroquine --- artemisinin --- onchocerciasis --- ivermectin --- moxidectin --- cancer --- vincristine --- vinblastine --- anabolic --- diabetes --- Duchenne muscular dystrophy --- β-ecdysone --- ecdysteroid --- ecdysterone --- Mas1 --- osteoporosis --- sarcopenia --- COVID-19 --- cardiometabolic diseases --- respiratory diseases --- natural product --- SARS-CoV-2 --- lung cancer --- United States Food and Drug Administration-approved drug --- natural remedy --- triterpenoid --- molecular ribbon --- Huisgen 1,3-dipolar cycloaddition --- amide bond --- multifunctional PEG3 derivative --- antimicrobial activity --- anti-HIV activity --- cytotoxicity --- supramolecular self-assembly --- phytocannabinoids --- cannabichromene --- thermos-TRPs --- TRPA1 --- α,α-dimethylheptyl effect --- betulinic acid --- BODIPY --- bevirimat --- cell-cycle --- fluorescent microscopy --- maturation inhibitor --- capsaicinoids --- endocannabinoidome --- microbiota --- overweight --- obesity --- food intake --- lipidomics --- metabolism --- alkaloids --- membrane fusion --- viral fusion inhibitor --- antiviral therapy --- curcumin --- cancer cells --- bioavailability --- curcumin derivatives --- curcumin analogues --- curcumin delivery systems --- natural product synthesis --- lignans --- inflammation --- NF-κB inhibition --- n/a